Dr Sarah PartridgeClinical Oncology in West London
Professional statement
Dr Sarah Partridge is a renowned consultant clinical oncologist in London. She offers patients personalised and holistic care during their cancer treatment, providing them with an opportunity to engage in hypnotherapy to achieve profound alterations in mood, well-being and symptom control.
Dr Partidge is a leading expert in her field who works closely with surgical and nursing teams. Her areas of expertise consist of thyroid cancer and head and neck cancer, including cancers of the larynx (voice box), tongue, tonsils and other rarer sites. She supervises and creates management plans for patients' individual needs, which can involve curative treatments with radiotherapy, postoperative radiotherapy treatments, chemotherapy and immunotherapy.
She graduated from Guy’s and St Thomas’ Hospital in 1990, following which she completed five years of postgraduate specialist training in oncology in London, based between Charing Cross, Guy’s and St Thomas’ and Mount Vernon hospitals. She has also completed a diploma with distinction in clinical hypnotherapy. Since 2002, she has practised at Charing Cross Hospital, which is where she developed a service for cancer patients as part of her role as lead for complementary therapy services.
Furthermore, Dr Partridge plays an active role in specialist training support within oncology as well as participating in the education of medical students. She also is on the Council for Hypnosis and Psychosomatic Medicine at the Royal Society of Medicine, promoting wider recognition and education regarding hypnosis.
Dr Partidge is a leading expert in her field who works closely with surgical and nursing teams. Her areas of expertise consist of thyroid cancer and head and neck cancer, including cancers of the larynx (voice box), tongue, tonsils and other rarer sites. She supervises and creates management plans for patients' individual needs, which can involve curative treatments with radiotherapy, postoperative radiotherapy treatments, chemotherapy and immunotherapy.
She graduated from Guy’s and St Thomas’ Hospital in 1990, following which she completed five years of postgraduate specialist training in oncology in London, based between Charing Cross, Guy’s and St Thomas’ and Mount Vernon hospitals. She has also completed a diploma with distinction in clinical hypnotherapy. Since 2002, she has practised at Charing Cross Hospital, which is where she developed a service for cancer patients as part of her role as lead for complementary therapy services.
Furthermore, Dr Partridge plays an active role in specialist training support within oncology as well as participating in the education of medical students. She also is on the Council for Hypnosis and Psychosomatic Medicine at the Royal Society of Medicine, promoting wider recognition and education regarding hypnosis.
Clinics
Thames View at Charing Cross Hospital
West London, Fulham Palace Road, W6 8RFMedical insurances accepted
Credentials
Professional experience
- 36 years of experience
- Consultant Clinical Oncologist, Charing Cross Hospital, West London (2000-present)
Subspecialties
- Clinical oncology
- Head and neck cancer
Education
- Good Clinical Practice Certification (refresher course) (2020)
- Diploma in Clinical Hypnotherapy (London College of Clinical Hypnosis) (Distinction) (2004)
Teaching posts
- College Representative for the Royal College of Radiologists.
- Member of the Council for Hypnosis and Psychosomatic Medicine at the Royal Society of Medicine.
Positions in organisations
- Honourary Secretary for the Council for Hypnosis and Psychosomatic Medicine at the Royal Society of Medicine.
- Primary Investigator for the VOLUME Study at Charing Cross (Sponsored by Bristol Myers Squibb) assessing the Retrospective experience of use of Nivolumab in the real world in patients with squamous cell Carcinoma Of the head & Neck (scchn) from Dec 2020
Publications and conferences
- Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer JAMA Oncol. 2019;5(12):1774-1778. doi:10.1001/jamaoncol.2019.2785
- Neoadjuvant Docetaxel/platinum/fluouracil (TPF) chemotherapy prior to concurrent chemoradiation in locally advanced head and neck cancer: a single institution study of acute toxicity and response evaluation. O.Hatcher, G. Anand, R.Wolfe, Elika Kashef, Gita Modani, S. Partridge, S. Stewart. Poster Presentation at 4th European Conference on Head & Neck Oncology in Athens 4-6 March 2010 Abstract: Eur Arch Otorhinolaryngol (2010) 267 (Suppl 1) S1-S117 (PP166)
Prizes and awards
- Henry Myers Exhibition for Psychological Medicine
Languages spoken
- English
Registration number: 3492608
Reviews
All reviews are from real patients and have been verified by our Customer Service department to ensure they meet our guidelines. Rules of the service
- Would you recommend this doctor?
- Treatment of the doctor
- Treatment of the staff
- Waiting time
- Condition of facilities
- Very kind and considerate, willing to answer any questions, good experience
- Such as fantastic doctor who truly cares for her patients even when she is off duty, and when necessary at any time of day. Any patient can feel really assured and safe when in Dr Partridges care.